‘With Risk Comes Opportunity’: Oppenheimer Suggests 2 Stocks to Buy, Including One With 170% Upside Potential

While the overall stock market direction so far this year remains up, the path ahead still presents plenty of potential headwinds. Inflation has yet to be properly tamed, the geopolitical map remains uncertain with Russia’s invasion of Ukraine still ongoing and Covid variants could reappear at any time. Add in the prospect for a fiery battle in Congress around raising the debt ceiling, and Oppenheimer’s Chief Investment Strategist John Stoltzfus thinks market volatility is “unlikely to leave the landscape.” However, these should not act as deterrents for stock investing, with Stoltzfus noting “there never is ‘an all clear signal’ sounded over the markets.” “Experience tells us that with opportunity comes risk and with risk comes opportunity whether in everyday life, businesses on Main Street, or in the Canyons of Wall Street,” he went to say, before championing “diversification.” With that idea in mind, let’s take a look at two stocks that Stoltzfus’ analyst colleagues at the banking firm believe make sound investment choices right now. In fact, one of them, according to the analysts, could surge as much as 170% over the next 12 months. Let’s take a closer look. Icosavax, Inc. ( ICVX ) The first name we’ll […]

You may also like...